Chronic Plaque Psoriasis Completed Phase 3 Trials for Etanercept (DB00005)

IndicationStatusPhase
DBCOND0033442 (Chronic Plaque Psoriasis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01358578Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type PsoriasisTreatment